Replimune Group Inc (REPL)
6.43
-0.29
(-4.32%)
USD |
NASDAQ |
May 17, 16:00
6.43
0.00 (0.00%)
Pre-Market: 20:00
Replimune Group Price to Book Value: 1.056 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 1.056 |
| May 16, 2024 | 1.102 |
| May 15, 2024 | 1.117 |
| May 14, 2024 | 1.100 |
| May 13, 2024 | 1.081 |
| May 10, 2024 | 1.051 |
| May 09, 2024 | 1.104 |
| May 08, 2024 | 1.095 |
| May 07, 2024 | 1.128 |
| May 06, 2024 | 1.150 |
| May 03, 2024 | 1.140 |
| May 02, 2024 | 1.076 |
| May 01, 2024 | 1.063 |
| April 30, 2024 | 1.041 |
| April 29, 2024 | 1.079 |
| April 26, 2024 | 1.053 |
| April 25, 2024 | 1.008 |
| April 24, 2024 | 1.038 |
| April 23, 2024 | 1.053 |
| April 22, 2024 | 1.053 |
| April 19, 2024 | 1.058 |
| April 18, 2024 | 1.143 |
| April 17, 2024 | 1.182 |
| April 16, 2024 | 1.172 |
| April 15, 2024 | 1.168 |
| Date | Value |
|---|---|
| April 12, 2024 | 1.171 |
| April 11, 2024 | 1.179 |
| April 10, 2024 | 1.141 |
| April 09, 2024 | 1.194 |
| April 08, 2024 | 1.168 |
| April 05, 2024 | 1.207 |
| April 04, 2024 | 1.204 |
| April 03, 2024 | 1.158 |
| April 02, 2024 | 1.169 |
| April 01, 2024 | 1.268 |
| March 28, 2024 | 1.190 |
| March 27, 2024 | 1.201 |
| March 26, 2024 | 1.120 |
| March 25, 2024 | 1.172 |
| March 22, 2024 | 1.194 |
| March 21, 2024 | 1.194 |
| March 20, 2024 | 1.181 |
| March 19, 2024 | 1.203 |
| March 18, 2024 | 1.206 |
| March 15, 2024 | 1.242 |
| March 14, 2024 | 1.287 |
| March 13, 2024 | 1.308 |
| March 12, 2024 | 1.267 |
| March 11, 2024 | 1.289 |
| March 08, 2024 | 1.315 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.857
Minimum
Dec 05 2023
9.258
Maximum
Dec 01 2020
2.847
Average
2.673
Median
Nov 14 2022
Price to Book Value Benchmarks
| Esperion Therapeutics Inc | -- |
| Gossamer Bio Inc | 5.875 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.44 |
| iBio Inc | 0.7501 |
Price to Book Value Related Metrics
| Price | 6.43 |
| Earnings Yield | -50.31% |
| Market Cap | 395.51M |